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A B S T R A C T   
The assessment of the actual contribution of red or processed meat to increasing the risk of suffering cardio-
vascular diseases (CVD) requires identification of specific harmful components and their underlying pathological 
mechanisms. In regards to CVD, meat lipids and their oxidation products have been recurrently studied due to 
their implications on lipid metabolism, hypercholesterolemia, obesity, and risk of suffering vascular events such 
as stroke. The impact of excess NaCl intake on increasing blood pressure is well-established and processed meat 
products have been recognized as a major contributor to dietary sodium in developed countries. Recent evidence 
has also suggested carnitine from red meat, as a precursor for trimethylamine-N-oxide, which has been shown to 
cause atherosclerosis, may increase the risk of suffering CVD in experimental animals. The present review aims 
to provide an updated overview, including evidence, controversies and unresolved questions on both the epi-
demiology and mechanisms relating red and processed meat consumption to CVD.   
1. Introduction 
Meat was first included in the diet by our human ancestors at least 3 
million years ago (McPherron et al., 2010). The inclusion of meat in 
human diets played a key role in human evolution. It is highly unlikely 
that evolving humans could have achieved their unusually large and 
complex brain together with their evolutionary trajectory as large, ac-
tive and highly social primates by eating solely vegetables (Milton, 
2003). In fact, nowadays, red meat keeps playing an important role in 
the human diet, providing an important source of macro- and micro-
nutrients. Meat is also highly appreciated by consumers for its sensory 
attributes and it is utterly tied to the gastronomy culture in many so-
cieties (Leroy & Cofnas, 2019). Red meat contains on average 20–24 g 
protein per 100 g fresh meat, being therefore considered a good source 
of high-quality protein. Red meat intake also provides other micro-
nutrients, such as B vitamins, iron, zinc, phosphorous and magnesium 
(Wyness, 2016). Thus, red meat is generally accepted amongst nutri-
tionists to be a valuable source of essential nutrients in a well-balanced 
diet. 
However, over the last decade, several meta-analyses of observa-
tional epidemiological studies have associated high red meat and pro-
cessed meat consumption with the onset of different health disorders 
(Abete, Romaguera, Vieira, Lopez de Munain, & Norat, 2014; Micha, 
Michas, & Mozaffarian, 2012; Yip, Lam, & Fielding, 2018). Amongst 
these pathological conditions, obesity and type II diabetes mellitus 
(T2D), colorectal cancer and cardiovascular disease (CVD) have at-
tracted particular attention owing to their severity (as summarized by  
Rohrmann & Linseisen, 2016, Wolk, 2017 and Ekmekcioglu et al., 
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2018). It is worth emphasizing that red meat and processed meats 
should be differentiated when investigating their association with the 
aforementioned health disorders. According to the World Health Or-
ganization (World Health Organization, 2015), red meat refers to all 
mammalian muscle meat, including, beef, veal, pork, lamb, mutton, 
horse, and goat. This WHO definition of red meat is openly misleading 
since meat from certain domestic and wild birds (e.g. duck, ostrich, 
partridge…) is much redder than that of some of the aforementioned 
mammals. Yet, it is generally understood that myoglobin and heme iron 
are the primary determinants for the identification of red versus white 
meat. In regard to processed meat, the WHO states that such meat has 
been transformed through salting, curing, fermentation, smoking, or 
other processes to enhance flavor or improve preservation. Most pro-
cessed meats contain pork or beef, but processed meats may also con-
tain other red meats, poultry, offal, or meat by-products such as blood. 
It is also necessary to highlight that processed meats include a great 
variety of additives, such as NaCl, nitrites, phosphates, etc. Hence, the 
broad categorization and poor definition of meats and their processed 
derivatives used in nutritional epidemiology urges for a careful inter-
pretation of the associations and does not allow to infer relative hazards 
for specific (processed) meats. 
The studies establishing connections between consumption of red 
meat and/or processed meat and health disorders (see Section 2) have 
consequently led health authorities and associations such as the 
American College of Cardiology and American Heart Association, to 
recommend lowering the consumption of unprocessed red meat and 
processed meat to reduce cardiovascular risk and high blood pressure 
(BP) (Eckel et al., 2014; Whelton et al., 2018). Yet, a set of recent 
studies published in the Annals of Internal Medicine concluded that, 
overall, the evidence linking processed and unprocessed red meat 
consumption and cardiometabolic disorders and cancer, are of low 
certainty, and that the assumed health benefits of reduced red meat 
consumption lack a sound scientific basis (Johnston et al., 2019;  
Vernooij et al., 2019; Zeraatkar et al., 2019). 
With implications that fresh red and processed meats are unhealthy, 
the application of strategies to achieve healthier meat products has 
been a hot topic in the field of meat science. Beyond epidemiological 
studies, the assessment of the actual contribution of particular fresh and 
processed meat components to increasing the risk of suffering health 
disorders, such as the abovementioned CVD, is essential. A detailed 
examination of the underlying pathological mechanisms of potential 
harmful components is required in order to design strategies for their 
mitigation if warranted. With regard to CVD, meat lipids have been 
recurrently studied due to their implications on lipid metabolism, hy-
percholesterolemia, obesity, and risk of suffering vascular events such 
as stroke (Nettleton, Brouwer, Geleijnse, & Hornstra, 2017). Owing to 
the effect of saturated fat intake on raising blood low-density lipopro-
tein (LDL)-cholesterol levels, and the observation that certain meats are 
relatively high in saturated fatty acids (SFA), producing and consuming 
leaner meats seemed reasonable in the past (Micha et al., 2012). 
However, this deduction negates the complex and variable fatty acid 
composition of meats, and the fact that the proportion of unsaturated 
fatty acids in most meat and meat products is higher than that of SFA 
(Wood et al., 2008). In addition, blood LDL levels seem to have a lower 
impact than its oxidized products (oxLDL) on CVD, since atherogenesis 
is initiated by oxidation of the lipids in LDL (Moss & Ramji, 2017). This 
mechanism, once initiated, is characterized by a positive feedback, in 
which oxLDL and the immune system play a crucial role (Buckley & 
Ramji, 2015; Ramji & Davies, 2015). Consequently, not only the total 
quantity of LDL, but also the oxidative balance should be monitored to 
assess the risk of suffering CVD. It is clear that this goes far beyond the 
SFA content of meats. 
The epidemiological risk for CVD is more affected by the con-
sumption of processed than by unprocessed meats (Ekmekcioglu et al., 
2018; Micha et al., 2012). This has been suggested to be due to the 
content of sodium and other preservatives present in processed meat 
products (Micha et al., 2012). In fact, processed meats contain around 
400% more sodium and 50 % more nitrates per gram than raw meat 
(Micha et al., 2012). The impact of NaCl on increasing BP is well-es-
tablished, and processed meat products have been recognized as one 
major contributor to dietary sodium in developed countries. Ad-
ditionally, nitrite concentrations in the blood have been correlated with 
endothelial dysfunction in humans (Rassaf et al., 2006), although re-
cent studies have found prolonged dietary nitrate supplementation do 
not affect atherogenesis or exert other detrimental effects (Marsch 
et al., 2016). Indeed, dietary nitrate/nitrite is associated with better 
cardiovascular functioning in humans. In the mouth, nitrate is con-
verted by bacteria to nitrite, which has vasodilating functions following 
absorption as nitric oxide (Borlaug, Koepp, & Melenovsky, 2015; Kapil 
et al., 2010). 
Amongst the micronutrients found in red meat, carnitine may have 
cardioprotective effects through facilitating transport of long-chain 
fatty acids into the mitochondrial matrix or by reducing oxidative 
stress, inflammation and necrosis of cardiac myocytes (Wang, Liu, Liu, 
Lu, & Mao, 2018). However, recent studies have implied metabolites of 
ingested carnitine and choline are associated with the onset of CVD. In 
particular, trimethylamine N-oxide (TMAO) (Koeth et al., 2013), pro-
duced from carnitine or choline, has been shown to be associated with 
atherosclerosis (Schiattarella et al., 2017). The involvement of human 
gut bacteria in the formation of trimethylamine (TMA) in the gastro-
intestinal tract prior to its uptake into the bloodstream, and the rate and 
extent of its conversion to TMAO in the liver reflect the complexity 
involved in trying to understand the mechanism of action and under-
lying pathology. Thus, the gut microbiome plays an essential role in 
TMAO blood levels, which becomes a potential target to implement 
strategies in order to prevent TMAO accumulation in the blood. 
The present review aims to provide an updated overview of the 
epidemiology and mechanisms in an effort to coalesce our current un-
derstanding of the effects of red and processed meat consumption on 
CVD with particular emphasis on meat lipids, NaCl and carnitine. 
2. Red and processed meat and CVD: epidemiological studies 
Numerous studies have been published on the association between 
meat consumption and various chronic diseases, summarized by  
Rohrmann and Linseisen (2016), Wolk (2017) and Ekmekcioglu et al. 
(2018). Studies on the epidemiological associations between red and 
processed meat consumption and cardiovascular diseases are listed in  
Table 1. Most studies basically differentiate between ‘red meat’, ‘pro-
cessed meat’ and/or ‘white meat’; a distinction which by itself is vague 
and debatable (Demeyer, Mertens, De Smet, & Ulens, 2016; Keeton & 
Dikeman, 2017). Variation in the definitions of these terms and dif-
fering allocation of specific foods to these groups likely contribute to 
the heterogeneity in conclusions across studies, in addition to other 
factors such as residual confounding (Rohrmann & Linseisen, 2016). 
‘Red meat’ usually refers to unprocessed beef, lamb and pork, ‘pro-
cessed meat’ refers to any meat preserved by curing, salting or smoking, 
and ‘white meat’ includes meat from poultry. 
Three meta-analyses were found summarizing the observational 
epidemiological studies on red meat, and processed meat consumption 
and all-case-mortality related to CVD (Abete et al., 2014; Pan et al., 
2012; Wang et al., 2016). All studies reported a significantly increased 
relative risk (RR) for CVD mortality, ranging between 15 and 21% for 
each serving of processed meat per day, or when the highest quintile of 
consumption was compared to the lowest. Nevertheless, a high het-
erogeneity (I2 not reported, or circa 75%) was observed in the analyses. 
The RR for red meat consumption with CVD mortality was either not 
significant (Wang et al., 2016), or significant (Abete et al., 2014; Pan 
et al., 2012), with unreported or high (I2 > 82.5%) heterogeneity. 
White meat consumption was not associated with CVD mortality, with 
very low heterogeneity in the analyses (I2=10.6) (Abete et al., 2014). 
Previously mentioned meta-analyses grouped all mortality related 
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to CVD altogether without making distinction between specific CVD. 
For example, in a previous study (Abete et al., 2014), death from CVD 
included mortality cases due to diseases of the circulatory system, is-
chemic heart disease (IHD) and cerebrovascular diseases (e.g. stroke). 
Another meta-analysis (Micha et al., 2012) reported a 42% increased 
RR for IHD incidence with the consumption of every 50 g of processed 
meat per day. In this meta-analysis, 83% weight was however given to a 
single prospective study in a USA population (Sinha, Cross, Graubard, 
Leitzmann, & Schatzkin, 2009). In opposition, red meat consumption 
was not associated with an increased RR for IHD incidence (Micha 
et al., 2012), and neither red, processed, nor white meat was associated 
with IHD mortality (Abete et al., 2014). These absent of associations 
were found in analyses with relatively few participants, and except for 
the analysis with white meat, heterogeneity was high or not reported. 
With regard to stroke, consumption of red meat and processed meat was 
associated with an increased RR of 9-13% and 13-17% respectively for 
all 4 available meta-analyses (Chen, Lv, Pang, & Liu, 2013; Kaluza, 
Wolk, & Larsson, 2012; Kim et al., 2017; Yang et al., 2016) with low or 
absent heterogeneity. These meta-analyses were however largely based 
on the same epidemiologic studies. In addition, Kim et al. (2017) found 
a negative association between white meat consumption and stroke, 
with a 13% lower RR of the highest quintile of white meat consumption 
versus the lowest. When the stroke subtypes were analyzed separately, 
the RR for ischemic stroke was increased by 13-25% by high red meat 
consumption in all 4 meta-analyses, by 15-19% for high processed meat 
consumption in 2 meta-analyses, and not significant in the 2 other 
meta-analyses. None of the meta-analyses showed any association be-
tween meat consumption and hemorrhagic stroke. 
In summary, available meta-analyses show negative or no associa-
tion between white meat consumption and CVD, whereas red and/or 
processed meat consumption seems to be associated with a higher RR 
for CVD all-cases-mortality, IHD incidence, total stroke, and/or is-
chemic stroke. Reported RR varied from 9 to 42% when comparing high 
vs. low consumption, or per serving per day, and a large heterogeneity 
was observed in meta-analyses on CVD and IHD mortality. These 
modest RR values may not be meaningful at the individual level, 
however, may have implications at the population level and be relevant 
from a public health perspective. For example, high processed meat 
consumption was estimated to contribute to 8.2% of cardiometabolic 
deaths in the USA, compared to 9.5% due to high sodium intake, and 
7.4% due to high consumption of sugar-sweetened beverages (Micha 
et al., 2017). In contrast, a series of recent studies published in the 
Annals of Internal Medicine stated that the evidence of these mentioned 
associations is of low certainty, based on the application of the GRADE 
tool (Vernooij et al., 2019; Zeraatkar et al., 2019; Zeraatkar, Han, et al., 
2019). The question remains if GRADE, originally designed to rate 
Table 1 
Overview of meta-analyses studying the epidemiological association between red meat (RM), processed meat (PM) and/or white meat (WM) consumption with the 
relative risk for cardiovascular disease (CVD), ischemic heart disease (IHD), total stroke, ischemic stroke and hemorrhagic stroke         
Studies Cases (participants) Relative risk  
(95% CI) 
Unit I2 (%)  
CVD mortality 
(Pan et al., 2012) 2 
2 
5 910 (121 342) 
5 910 (121 342) 
RM: 1.18 (1.13-1.23) 
PM: 1.21 (1.13-1.31) 
serving/d 
serving/d 
- 
- 
(Abete et al., 2014) 7 42 530 (1 615 868) RM: 1.16 (1.03-1.32) H vs. L 82.5** 
6 35 537 (1 186 761) PM: 1.18 (1.05-1.32) H vs. L 73.7** 
6 36 620 (1 494 526) WM: ns H vs. L 10.6 
(Wang et al., 2016) 6 22 222 (947 015) RM: ns H vs. L 84.5** 
6 33 278 (1 195 947) PM: 1.15 (1.07-1.24) serving/d 75.4** 
IHD incidence      
(Micha et al., 2012) 4 769 (56 311) RM: ns 100 g/d - 
5 21 308 (614 062) PM: 1.42 (1.07-1.89) 50 g/d - 
IHD mortality      
(Abete et al., 2014) 3 716 (64 109) PM: ns H vs. L 81.7** 
4  > 928* (230 693) RM: ns H vs. L 70.3** 
3 928 (196 495) WM: ns H vs. L 0 
Total stroke      
(Kaluza et al., 2012) 5 
4 
10 630 (329 495) 
9 581 (242 470) 
RM: 1.11 (1.03-1.20) 
PM: 1.13 (1.03-1.24) 
serving/d 
serving/d 
0 
37.8 
(Chen et al., 2013) 4 
4 
9 593 (239 251) 
9 593 (239 251) 
RM: 1.09 (1.01-1.18) 
PM: 1.14 (1.05-1.25) 
H vs. L 
H vs. L 
0 
23 
(Yang et al., 2016) 4 
4 
9 581 (242 470) 
9 581 (242 470) 
RM: 1.13 (1.04-1.22) 
PM: 1.17 (1.09-1.27) 
H vs. L 
H vs. L 
0 
0 
(Kim et al., 2017) 5 
5 
2 
9 522 (254 742) 
9 522 (254 742) 
4 759 (138 761) 
RM: 1.11 (1.03-1.20) 
PM: 1.17 (1.08-1.25) 
WM: 0.87 (0.78-0.97) 
H vs. L 
H vs. L 
H vs. L 
0 
0 
0 
Ischemic stroke      
(Kaluza et al., 2012) 4 
4 
6 420 (289 146) 
5 371 (202 121) 
RM: 1.13 (1.00-1.27) 
PM: 1.15 (1.06-1.24) 
serving/d 
serving/d 
- 
- 
(Chen et al., 2013) 3 
3 
5 371 (202 121) 
5 371 (202 121) 
RM: 1.13 (1.01-1.25) 
PM: 1.19 (1.08-1.31) 
H vs. L 
H vs. L 
- 
- 
(Yang et al., 2016) 4 
1 
4 220 (1 979 276) 
2 212 (127 160) 
RM: 1.15 (1.03-1.29) 
PM: ns 
H vs. L 
H vs. L 
0 
27.6 
(Kim et al., 2017) - 
- 
- 
- 
RM: 1.24 (1.05–1.46) 
PM: ns 
H vs. L 
H vs. L 
17.7 
11.7 
Hemorrhagic stroke      
(Kaluza et al., 2012) 4 1 276 (289 146) RM and PM: ns serving/d - 
(Chen et al., 2013) 3 1 276 (202 121) RM and PM: ns H vs. L - 
(Yang et al., 2016) 5 1 931 (1 391 196) RM ns H vs. L 43.7  
3 1 276 (202 121) PM: ns H vs. L 18.6 
(Kim et al., 2017) - - RM and PM: ns H vs. L 0/8.1 
* One of the studies does not specify the amount of cases; H vs. L= highest vs lowest quintile of intake. RM= red meat; PM= processed meat; WM=white meat: 
CVD= cardiovascular disease; IHD=ischemic heart disease. ** = P-value < 0.05  
J. Delgado, et al.   Meat Science 171 (2021) 108278
3
clinical drug trials, should be applied to public health epidemiological 
studies, since observational data start this evidence weighting process 
with a rating of ‘low evidence’ and may be further downgraded to ‘very 
low’ (Neuhouser, 2020). 
3. Underlying pathological mechanisms of red and processed 
meat consumption on CVD 
3.1. Lipids 
The lipid fraction of meat, particularly some species, is character-
ized by relatively high amounts of SFA and cholesterol, whose dietary 
intake has been traditionally associated to a higher risk of CVD. 
Furthermore, polyunsaturated fatty acids (PUFA) in meat are sensitive 
to oxidation, which may also contribute to CVD risk. An evaluation of 
the mechanisms underlying these statements is presented in this sec-
tion. 
3.1.1. Cholesterol 
The cholesterol content of meat depends on species, type of product 
and cooking treatment, and is approximately 50-100 mg/100g fresh 
meat (Dinh, Thompson, Galyean, Patterson, & Boylan, 2011). The mean 
cholesterol intake in US adults in 2013-2014 was estimated at 290 mg/ 
day and has remained unchanged over the past 10 years, with con-
tribution of meat and meat products estimated to be approximately 
42% (Xu, McClure, & Appel, 2018). 
Lifelong exposure to elevated LDL cholesterol blood levels has been 
confirmed to be a cause of atherosclerotic cardiovascular disease 
(Gidding & Allen, 2019), an inflammatory disorder of the arterial wall. 
In fact, atherogenic lipoproteins have the ability to infiltrate the arterial 
wall and to bind extracellular molecules (Gidding & Allen, 2019). Then, 
they become trapped and are modified through oxidation, increasing 
their inflammatory properties and contributing to form a fibrous 
plaque, which can cause stenosis and tissue ischemia (Figure 1). 
Moreover, when plaque rupture occurs, subendothelial components are 
exposed to the blood, leading to luminal thrombosis, which can po-
tentially give rise to occlude arterial flow (Jacobson et al., 2015). A 
recent meta-regression analysis that used data from randomized dietary 
intervention trials pointed out that, after adjustment for dietary fatty 
acids, changes in dietary cholesterol were positively associated with 
changes in blood LDL-cholesterol concentration (Vincent, Allen, 
Palacios, Haber, & Maki, 2019). 
However, it is nowadays questioned whether high LDL cholesterol 
levels are responsive to high intakes of cholesterol, and thus, it is under 
debate whether dietary cholesterol is associated to CVD. It has been 
reported that dietary cholesterol accounts for approximately 5 % higher 
serum cholesterol levels as compared to fasting conditions (Berger, 
Raman, Vishwanathan, Jacques, & Johnson, 2015; Grundy, 2016).  
Grundy (2016) also reported that different mechanisms protect against 
marked hypercholesterolemia with the suppression of cholesterol 
synthesis and an enhanced conversion of cholesterol into bile acids 
being among them. Furthermore, according to the American Heart 
Association (AHA) and the American College of Cardiology (ACC) there 
is insufficient evidence to advise reducing dietary cholesterol for low-
ering LDL-cholesterol (Eckel et al., 2014). In addition, to date, extensive 
research in population studies did not show evidence to support a role 
of dietary cholesterol in the development of CVD (Soliman, 2018). In its 
report “Dietary reference values for fats”, the European Food Safety 
Authority (EFSA) concludes that, at current levels of intake, available 
data on the relationship between cholesterol intake and cardiovascular 
disease are inconsistent (EFSA, 2010), so no particular restriction of 
dietary cholesterol is suggested by this health authority. Similarly, the 
recommendation from the 2010 Dietary Guidelines to limit consump-
tion of dietary cholesterol to 300 mg per day is no longer included in 
the 2015 edition (HHS & USDA, 2015). On the contrary, the National 
Lipid Association (NLA) recommends < 7% of calories from saturated 
fat and < 200 mg/day of dietary cholesterol (Jacobson et al., 2015). 
Discrepancies about the role of dietary cholesterol on CVD might be 
linked to the fact that most foods with high cholesterol content are also 
rich in SFA, a known determinant of serum cholesterol levels (Soliman, 
2018). Thus, further research that controls for saturated fat intake is 
required to conclude about the contribution of dietary cholesterol to 
lipid/lipoprotein levels and CVD risk (Bowen, Sullivan, Kris-Etherton, & 
Petersen, 2018). 
3.1.2. SFA 
There is a long-held perception that meat consumption greatly 
contributes to total SFA intake. SFA account for approximately 30 to 
Fig. 1. Underlying mechanisms of the pathophysiological effects of dietary lipids on CVD.  
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45% of total fatty acids in intramuscular or subcutaneous fat depots, 
depending on several factors such as type of fat depot, species, and, 
above all, the animals’ feeding background (Raes, De Smet, & Demeyer, 
2004; Wood et al., 2008). Ruminants’ fat depots are generally more 
saturated compared to monogastric animals due to the rumen biohy-
drogenation process. This is accompanied by the deposition of a broad 
spectrum of biohydrogenation intermediates, with some of them dis-
playing beneficial health properties (e.g. conjugated linoleic acid or 
vaccenic acid) (Dugan, Aldai, Aalhus, Rolland, & Kramer, 2011), which 
may be isomer specific. In addition, and even more important, it should 
be realized that the total fat content of many fresh meats is lower than 
5%, hence only contributing modestly to total fat and SFA intake. In-
deed, in a cross-European study, the contribution of total meat and 
meat products intake to total SFA and total trans fatty acids intake 
varied among countries between 14 and 29% and between 5 and 30% 
respectively (Hulshof et al., 1999). These figures are hard to reconcile 
with a supposed effect of red meat consumption on CVD owing to the 
dietary contribution of such meat in terms of SFA and trans fatty acids. 
During the last decades, an association between a high SFA intake 
and an increased risk of CVD was generally accepted, explained by the 
stimulating effects of dietary SFA intake on blood lipoprotein-choles-
terol levels (Willett, 2012). However, an increasing number of studies 
point out certain controversy about this association (Hoenselaar, 2012;  
Kuipers, De Graaf, Luxwolda, Muskiet, & Muskiet, 2011; Ruiz-Núñez, 
Dijck-Brouwer, & Muskiet, 2016; Siri-Tarino, Sun, Hu, & Krauss, 2010; 
Yongjian Zhu, Bo, & Liu, 2019). In fact, the prospective cohort PURE 
study (Dehghan et al., 2017), compiling epidemiological data from 18 
countries, reported an inverse association between SFA intake and 
stroke risk and no association between total fat and individual types of 
fat, and cardiovascular disease, myocardial infarction or cardiovascular 
disease mortality. Yet, a positive association between total fat and SFA 
with blood pressure was reported (Mente et al., 2017). However, the 
latter study also mentioned that replacing SFA with carbohydrates had 
adverse effects on blood lipids, whereas replacement of SFA with un-
saturated fatty acids (UFA) decreased LDL and blood pressure, but also 
decreased high density lipoprotein (HDL). Indeed, Ruiz-Núñez et al. 
(2016) reviewed that the influence of SFA on CVD risk depends on the 
total energy, the balance between omega-3 and omega-6 PUFA and the 
amounts of carbohydrates in the diet, next to many other lifestyle 
factors. Moreover, assorted studies show that not all SFA exert phy-
siological effects alike, and actually, it is known that their effects on 
CVD diseases are diverse. Stearic acid (18:0) consumption is known to 
not be deleterious because it can be converted to oleic acid (18:1) 
(Hunter, Zhang, Kris-Etherton, & Childs, 2010). Higher levels of cir-
culating 18:0, 20:0, 22:0, and 24:0 were each also associated with a 
lower risk of atrial fibrillation (AF), while palmitic acid (16:0) increased 
the risk (Fretts et al., 2014). Moreover, no correlation has been found 
between SFA intake and the SFA status (amount in the organism) 
(Forsythe et al., 2008; Volek, Fernandez, Feinman, & Phinney, 2008). In 
addition, the intake of SFA not only raises LDL-cholesterol, but also 
raises the beneficial HDL-cholesterol, with HDL-raising effects being 
greater as the SFA chain-length decreases (Micha & Mozaffarian, 2010). 
In addition to the effect of SFA intake on blood lipoprotein levels, 
the consumption of SFA may also affect cardiovascular health through 
other mechanisms including inflammation. Due to the limited number 
of intervention studies involving meat and/or meat products to explain 
some of the potential mechanisms participating in this connection, 
studies with other SFA sources are described here as well, to elaborate 
on this hypothesis. The consumption of SFA (coconut oil) vs. PUFA 
(safflower oil) impaired the ability of HDL to inhibit the expression of 
pro-inflammatory adhesion molecules (ICAM-1 and VCAM-1) by en-
dothelial cells, and also caused an impairment of vascular reactivity 
(Nicholls et al., 2006). The latter study may however have been con-
founded by the strongly contrasting vitamin E contents of the fat 
sources used (Masterjohn, 2007). In contrast, no changes were observed 
in ICAM and VCAM in blood of volunteers with moderate CVD risk, 
following the substitution of circa 10% total energy dietary SFA (butter) 
with either MUFA (olive oil, rapeseed oil) or n-6 PUFA (safflower oil) 
(Vafeiadou et al., 2015). However, this substitution improved the blood 
lipoprotein profile, and decreased circulating endothelial and platelet 
microparticle numbers, suggesting beneficial effects on endothelial re-
pair and maintenance (Weech et al., 2018). Consumption of meat en-
riched with walnuts (source of PUFA and other nutrients) vs. lean meat 
lowered the levels of ICAM and VCAM, but also of leukotriene B4 in 
blood of humans at increased cardiovascular risk (Canales et al., 2011). 
However, the effects of meat consumption on inflammation are not well 
described and often conflicting, likely not only explained by differences 
in their fatty acid profile, but also in the sensitivity of the meat to form 
PUFA-derived oxidation products or other potentially harmful meta-
bolites during processing and gastrointestinal digestion (Van Hecke, 
Van Camp, & De Smet, 2017). Indeed, oxidative stress is closely inter-
related with vascular inflammation, endothelial dysfunction and vas-
cular damage (Siti, Kamisah, & Kamsiah, 2015). Recent research by  
Joseph et al. (2019) showed that the intake of SFA (palm oil) by mice, 
can also increase oxidative stress in cardiomyocytes by activating 
NOX2, resulting in abnormalities of calcium homeostasis and heart 
rhythm, before the onset of obesity. 
During the last two decades, many studies have been conducted to 
‘improve’ the fatty acid profile of fresh meat and meat products, either 
by modifying animal diets or by adding PUFA rich fat sources during 
meat processing (Alejandre, Astiasarán, & Ansorena, 2019; Ansorena & 
Astiasarán, 2014; De Smet & Vossen, 2016; Dugan et al., 2011). Most of 
these studies focused on enhancing the PUFA content, thereby in-
directly lowering the SFA content, and on lowering the n-6/n-3 FUFA 
ratio. Several of these approaches have been implemented in com-
mercial practice, meaning that there are nowadays omega-3 enriched 
meat products in the market and that there is more variation in meat 
fatty acid composition than generally anticipated. Unfortunately, few 
intervention studies have investigated the impact of their consumption 
on cardiovascular health. It was reviewed that enrichment of meat with 
alpha-linolenic acid generally does not affect blood lipoproteins upon 
consumption in humans, whereas some positive effects were reported 
with consumption of meats enriched with long chain n-3 PUFA (De 
Smet & Vossen, 2016). In more recent studies, beef fat enriched with 
PUFA biohydrogenation products improved insulin sensitivity in insulin 
resistant rats (Diane et al., 2016). Similarly, it has been reported that 
the daily intake of broth from meat of linseed-fed cattle had a positive 
had a positive effect on insulin sensitivity in healthy human volunteers 
(Bacs et al., 2019). Further human intervention studies are definitely 
needed to properly assess the effect of meat fatty acid composition on 
human health and the risk of chronic diseases. Taking into account all 
this information, it is clear that the presumed effects of meat and meat 
product consumption on risk of CVD cannot be simply deduced to be 
due to the SFA content. Further investigations on effects of the complete 
fatty acid profile of meat and meat products are needed in order to 
establish their roles in the development of CVD. 
3.1.3. Oxidized lipids 
In addition to the role of LDL cholesterol in atherogenesis, the role 
of oxidized lipoproteins in the etiology of vascular impairment has also 
been widely demonstrated (Ahotupa, 2017). In fact, certain type of li-
pids such as PUFA-containing phospholipids and cholesterol esters are 
easily oxidized under oxidative stress, forming a complex mixture of 
oxidation products, which are actively involved in the inflammatory 
responses in atherosclerosis by interacting with immune cells and en-
dothelial cells (Testa, Rossin, Poli, Biasi, & Leonarduzzi, 2018; Zhong 
et al., 2019). Oxidized lipids can be formed endogenously, but they can 
also be ingested from the diet due to lipid oxidation in foods caused by 
heat treatments, contact with oxygen, exposure to sunlight, etc. 
(Otaegui-Arrazola, Menéndez-Carreño, Ansorena, & Astiasarán, 2010). 
In direct evidence, it has been reported when rabbits were fed oxidized 
fatty acids or oxidized cholesterol, the fatty streak lesions in the aorta 
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were increased by 100% (Staprans, Pan, Rapp, & Feingold, 2005). 
These authors also showed that oxidized dietary cholesterol sig-
nificantly increased aortic lesions in apo-E and LDL receptor-deficient 
mice. 
Lipid oxidation also occurs during the passage of meat through the 
different compartments of the gastrointestinal system, and is promoted 
by the presence of heme iron, higher levels of PUFA, and the absence of 
suitable antioxidants (Van Hecke, Van Camp, & De Smet, 2017). The 
oxidation of n-6 PUFA and n-3 PUFA lead to the specific formation of 4- 
hydroxy-2-nonenal (HNE) and 4-hydroxy-2-hexenal (HHE) respec-
tively, whereas malondialdehyde (MDA) can originate from both PUFA 
sources. These lipid oxidation products have a varying toxic potential, 
and can be absorbed into the blood and in turn can cause LDL mod-
ification (Kanner, Gorelik, Roman, & Kohen, 2012). Included with 
various other proatherogenic mechanisms, HNE can induce dysfunction 
of endothelial nitric oxide synthase (eNOS), whereby it reduces the 
formation of vasodilating nitric oxide, and increases blood pressure 
(Nègre-Salvayre & Salvayre, 2018). Consequently, minimizing the oxi-
dation of lipids during meat storage and processing, and during gas-
trointestinal digestion might contribute to a decreased risk of CVD. 
Indeed, Gorelik, Kanner, Schurr, and Kohen (2013) demonstrated in a 
human intervention study that an increase in blood MDA-LDL following 
the consumption of turkey meat can be completely prevented by the 
simultaneous ingestion of red wine polyphenols. The addition of phe-
nolic-rich spices and herbs during meat processing (Van Hecke, Ho, 
Goethals, & De Smet, 2017), or curing with nitrite salt (Van Hecke 
et al., 2014) can almost completely prevent lipid oxidative damage 
during gastrointestinal digestion of meat. Also, the use of fiber with 
antioxidant properties in meat-based products has been shown to delay 
lipid oxidation during storage (Das, Nanda, Madane, Zhang, & Lorenzo, 
2020). However, the high salt content in cured meat may promote CVD 
by other mechanisms, as further described. Also, since a large formation 
of n-3 PUFA oxidation products occurs during the digestion of fish 
compared to meat (Steppeler, Haugen, Rødbotten, & Kirkhus, 2016;  
Van Hecke, Goethals, Vossen, & De Smet, 2019), and fish consumption 
is generally considered as beneficial for cardiovascular health, question 
remains to what extent these lipid oxidation products are involved in 
development of CVD. 
3.2. NaCl 
Sodium is an essential nutrient, being necessary for neuro-
transmission and normal cell homeostasis. Most sodium in the human 
diet is associated with chloride, as NaCl. The minimum physiological 
requirement for this element is estimated to be 200-500 mg/day (about 
0.5-1.25 g of NaCl/day), whilst the average amount of sodium con-
sidered as adequate is around 1.5 g/day (3.8 g NaCl/day). The re-
commended sodium consumption for adults, which is 2 g sodium/day 
(equivalent to 5 g salt/day), is exceeded by consumers in many coun-
tries (World Health Organization, 2012). These recommendations and 
limitations arise from the fact that NaCl does have a deep impact on 
consumer’s health, as will be argued later. It is noteworthy, however, to 
highlight that NaCl might have a more important role in salt-sensitive 
hypertension than sodium intake than from other sources such as so-
dium bicarbonate (Mohammadifard et al., 2018) 
At this point we must discriminate between the NaCl intake from 
meat and processed meat products. Whilst the NaCl quantity in the 
former is negligible, the latter have been recognized as a major con-
tributor to dietary sodium in developed countries, mainly due to the 
content of sodium and other preservatives present in these processed 
products. In fact, processed meats contain around 400 % more sodium 
and 50 % more nitrates per gram than fresh meats (Micha et al., 2012). 
In general, in European countries, meat products are the second highest 
contributors to NaCl intake (19%), whereas bakery products and cereals 
contribute 36% (Kloss, Meyer, Graeve, & Vetter, 2015; Marrero, He, 
Whincup, & MacGregor, 2014). Interestingly, the two countries within 
the EU where meat products have the highest impact on total NaCl 
intake are Spain and Norway. Similarly, in the United States, processed 
meat products are the second contributor to dietary sodium intake, 
after bakery products (Centers for Disease Control and Prevention, 
2011). 
NaCl plays a key role in meat products, particularly in dry-cured 
products. The added salt enhances protein solubility, dehydrates the 
product and contributes to microbial stability through water activity 
reduction. Additionally, NaCl is a powerful flavoring, which makes it 
extremely difficult to reduce its quantity without losing the desired 
sensory properties. However, as stated previously, the average NaCl 
intake is beyond the general recommendations in many countries, 
which has a clear negative impact on health. Strazzullo, D’Elia, 
Kandala, and Cappuccio (2009) report strong relationships and links 
between sodium intake, hypertension and CVD based on analysis of 
prospective studies. It has been estimated that 90% of heart failure 
hospitalizations in the United States and Europe are due to symptoms 
and signs of sodium and fluid excess (Costanzo & Jessup, 2012). Ad-
ditionally, there were around 1.65 million deaths worldwide in 2010, 
associated with increased BP and CVD caused by high sodium intake. 
These deaths represented about 1 out of 10 deaths due to CVD, and 2 
out of 5 deaths were premature (before 70 years of age) (Mozaffarian 
et al., 2014). In line, Micha et al. (2017) estimated the largest pro-
portion of all cardiometabolic deaths (9.5%) were related to high so-
dium intake in comparison 8.2% to high processed meat, and 7.4% to 
sugar sweetened beverages. 
The physiological mechanisms underlying BP are not fully eluci-
dated, but, in general, alterations in renal function, hormones involved 
in fluid excretion/retention, the vasculature, the heart, and/or central 
sympathetic outflow are involved (Farquhar, Edwards, Jurkovitz, & 
Weintraub, 2015). Endothelial function is reduced in arteries by sodium 
loading in normotensive men, whilst the restriction of this element in 
hypertensive patients provokes an improvement in endothelial function 
(Jablonski et al., 2013; Tzemos, Lim, Wong, Struthers, & MacDonald, 
2008). The deleterious effect of sodium on endothelial function has 
been linked to reactive oxygen species (ROS) increment, particularly of 
superoxide, which in turn decreases the vasodilator effects of nitric 
oxide in endothelium (Nurkiewicz & Boegehold, 2007). High levels of 
sodium have been also found to stiffen the arteries through ROS and 
endothelium sodium channels which provoke a reduction in the elastin/ 
collagen ratio (Salvi, Giannattasio, & Parati, 2018). The heart is the 
main organ suffering the consequences of increased BP in the long term, 
with left ventricular hypertrophy as the most common pathology 
(Farquhar et al., 2015). Figure 2 illustrates the harmful effect of excess 
NaCl intake on vascular function. 
One of the main problems that needs to be addressed is the differ-
ence in sensitivity of BP to alterations in dietary sodium, leading to the 
concept of salt-sensitive (SS) and salt-resistant (SR) individuals, which 
has been known about for many years (Weinberger, 1996). The former 
group comprises aged, hypertensive, chronic kidney disease-suffering 
or low birth weight people, whilst the latter includes young, middle- 
aged and normotensive people (Farquhar et al., 2015). Additionally, the 
use of nonsteroidal anti-inflammatory drugs (e.g. ibuprofen) increases 
BP, via prostaglandin synthesis inhibition which leads to renal and 
systemic vasoconstriction that in turns increases sodium and water re-
tention. The high sodium intake in combination with this kind of drugs 
is of utmost relevance, especially for older people, who routinely take it 
for chronic pain. This fact could increase the incidence of heart failure 
(Chrysant, 2016). Then, the general nutritional recommendations are 
only applicable to the normotensive population, and several criteria 
have to be considered to develop recommendations for particular 
groups. 
In general terms, it is accepted that dietary sodium reduction to-
wards the WHO guidelines leads to a significant reduction in BP and 
cardiovascular disease risk (Choi, Brandeau, & Basu, 2016; Nghiem, 
Blakely, Cobiac, Pearson, & Wilson, 2015). Particularly, a linear 
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association between salt restriction and systolic BP has been shown, as 
well as a reduction of sodium intake lowers arterial stiffness in hy-
pertensive patients (Farquhar et al., 2015). Thus, strategies are required 
for limiting the sodium content in foods, especially in processed meat 
products as one of the highest contributors of salt to the diet. 
Given the key role played by NaCl in processed meats, the reduction 
in NaCl is limited by the desired physicochemical properties to achieve 
product, flavor and microbial stability. Thus, the most extensive 
strategy followed has been replacing this salt by others containing po-
tassium, calcium, and/or magnesium instead of sodium. This strategy 
has been proven to be effective to reduce BP (Sarkkinen et al., 2011). 
The use of these salts requires optimization of the processes to achieve 
the desired sensory properties of the final product (Allison & 
Fouladkhah, 2018). These salts also partially modify the taste of the 
product, particularly, bitterness is the most common flavor detected in 
these products (Armenteros, Aristoy, Barat, & Toldrá, 2012). On the 
other hand, the impact of sodium intake through unprocessed meat 
products is greatly limited due to the low natural levels (Micha et al., 
2012). The sodium intake from fresh meats will depend on the amount 
of salt added at the table based on consumer preference (Brown, 
Tzoulaki, Candeias, & Elliott, 2009). 
It is a worthy strategy to reduce the sodium content in meat pro-
ducts. However, combining strategies to minimize the pathophysiolo-
gical mechanisms of dietary salt may also be required. High ROS gen-
eration provokes oxidative stress. This phenomenon lowers nitric oxide 
synthesis, which in turn reduces vasodilatation, increasing BP. Then, 
new strategies based on balancing these effects are required. As an 
example, flavonoid-rich beverages consumption has been associated 
with a reduction in coronary events, particularly, flavanol-rich cocoa 
has been found to activate nitric oxide synthase, providing a plausible 
mechanism for the protection that flavanol-rich foods induce against 
coronary events (Fisher, Hughes, Gerhard-Herman, & Hollenberg, 
2003). Therefore, antioxidants included as ingredients in meat products 
may contribute to tackle the cited deleterious effects. The combination 
of the inclusion of these compounds in meat products with NaCl re-
duction/replacement may help to mitigate the detrimental effects of 
sodium intake from processed meats related with CVD. 
3.3. Carnitine 
L-carnitine, commonly refered to as carnitine, is a natural and 
biologically active amino acid derivative, which transports activated 
long chain fatty acids from the cytosol into mitochondria for subsequent 
β-oxidation, and supports other physiological activities (Knüttel- 
Gustavsen & Harmeyer, 2011; Wang et al., 2018). Carnitine is not 
considered an essential nutrient (Vaz & Wanders, 1982), although it 
might be regarded as a conditionally essential nutrient during certain 
physiological conditions. 
Carnitine enters the body through animal-derived food intake as 
milk-based or meat products. The concentration of this nutrient varies 
greatly amongst different animal-derived foods with meat-based pro-
ducts containing much higher carnitine concentrations than milk-based 
products. With regard to the meat carnitine content, raw meat from 
beef contains c.a. 70 mg/100g, chicken 10 mg/100g, turkey 21 mg/ 
100g, duck 27 mg/100g, lamb 40 mg/100g and pork 30 mg/100g 
(Demarquoy et al., 2004). However, depending on the cooking process 
that the meat underwent, the carnitine content can drop up to 50% 
(Knüttel-Gustavsen & Harmeyer, 2011). Thus, the cooking process 
seems to substantially alter the content of this nutrient, which is of 
utmost interest in order to calculate carnitine intake. 
For many years, carnitine has been known to have antioxidant ef-
fects and has been demonstrated to exert beneficial effects on plasma 
proteins by inhibiting peroxidation induced by peroxynitrites through 
direct scavenging of free radicals (Reznick et al., 1992). Carnitine has 
also been shown to chelate catalytic metals-promoters of ROS, and in-
hibit ROS-generating enzymes. It also affects redox-signaling via acti-
vation of Nrf2, PPARα and inhibits NF-κB by enhancing the synthesis of 
antioxidant enzymes (Kolodziejczyk, Saluk-Juszczak, & Wachowicz, 
2011; Reznick et al., 1992; Yang, Yang, & Cao, 2015). These physio-
logical effects may lead to a beneficial impact on CVD through reduc-
tions in stress-induced hypertension, diabetic ketoacidosis, hyper-
osmolar hyperglycemia, insulin-dependent diabetes mellitus, insulin 
resistance and obesity (Wang et al., 2018). Considering these biological 
activities, carnitine has successfully been used at supra-nutritional 
doses as a supplement for treating CVD (DiNicolantonio, Lavie, Fares, 
Menezes, & O’Keefe, 2013). Researchers have calculated a 40% re-
duction in anginal symptoms in patients experiencing an acute myo-
cardial infarction with carnitine supplementation compared to placebo 
controls. 
Nevertheless, over the last decade any positive aspect about carni-
tine intake has been brought into question because it is a precursor of 
TMAO, a metabolite suggested to be involved in atherogenesis (Koeth 
et al., 2013). Briefly, TMA is produced from choline and carnitine by 
various taxa present in the gut microbiota. TMA is then absorbed via 
the intestinal epithelium and metabolized to TMAO in the liver (Rath, 
Heidrich, Pieper, & Vital, 2017). 
The carnitine oxygenase (cntA) enzyme is essential for gut microbial 
transformation of carnitine into TMA. CntA belongs to a group of pre-
viously uncharacterized Rieske-type proteins, and has an unusual 
“bridging” glutamate but not the aspartate residue. The taxa endowed 
Fig. 2. Underlying mechanisms of the pathophysiological effects of NaCl on CVD.  
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with cntA are Gamma- and Betaproteobacteria, as well as a few from 
Firmicutes. Additionally, Acinetobacter baumannii and Escherichia coli 
have been functionally proven to require this protein for TMA forma-
tion (Rath et al., 2017; Zhu et al., 2014). Nonetheless, a recent study 
points out that cntA is not a good biomarker for identifying TMAO 
producers, and there might be other potential microbial genes re-
sponsible for carnitine metabolism to TMA in gut microbiota (Wu et al., 
2018). Given the complexity of the gut microbiota composition, it can 
be inferred that further studies are required to decipher the micro-
organisms and their biochemical mechanisms involved in TMA forma-
tion. Finally, once TMA is produced by microorganisms, it is further 
oxidized to TMAO by flavin monooxygenases in the liver (Koeth et al., 
2013). 
Numerous studies indicate that TMAO is associated with athero-
sclerosis, and there is a positive dose-dependent association between 
TMAO plasma levels and increased cardiovascular risk as well as 
mortality (Koeth et al., 2013; Schiattarella et al., 2017). There are 
several pathological mechanisms explaining the effect of TMAO on 
health. 
Cholesterol transport has been proven to be negatively influenced 
by this metabolite, because of the suppression of reverse cholesterol 
transport (Koeth et al., 2013). TMAO also promotes vascular in-
flammation and increases platelet reactivity along with associated 
augmentation of thrombotic event risk, meaning higher risk of myo-
cardial infarction and stroke (Seldin et al., 2016; Zhu et al., 2016). On 
the other hand, some criticism can be found regarding the causal link 
between TMAO and CVD, since fish and seafood contain considerable 
amounts of free TMAO, which is in contrast with the generally accepted 
cardioprotective properties of fish consumption (Landfald, Valeur, 
Berstad, & Raa, 2017). Specifically, fish intake by healthy humans re-
sulted in 46-62 times higher circulating and urinary TMAO levels 
compared to the intake of eggs or beef (Cho et al., 2017), which raises 
doubts on the relevance of carnitine intake from meat on CVD through 
the formation of TMAO. This finding suggests that TMAO alone, may 
not explain the epidemiological link between red meat consumption 
and CVD, and mechanisms are probably more complicated. Along this 
line, some studies suggested that TMAO may be a biomarker for im-
paired kidney function and poor metabolic control rather than having a 
causative role on CVD (Mueller et al., 2015), or may reflect a specific 
colon microbial composition associated with CVD (Cho et al., 2017). It 
was recently also hypothesized that increased plasma TMAO would 
serve as a compensatory response to hydrostatic and osmotic stress in 
CVD (Ufnal & Nowiński, 2019). Figure 3 shows the underlying 
mechanism of carnitine as precursor of TMAO and some unresolved 
dilemmas in relation to its role as promoter of CVD. 
Nevertheless, a diet enriched in red meat compared to white meat 
has been associated with increased blood TMAO levels (Koeth et al., 
2013). This relationship is explained by the increased microbial TMA/ 
TMAO production from carnitine. A discontinuation of red meat intake 
reduced plasma TMAO levels within 4 weeks (Wang et al., 2019). 
Taking only this information into consideration, the reduction of red 
meat within a healthy diet should be recommended. However, carnitine 
exerts positive effects as mentioned above, and most importantly, the 
TMAO formed from carnitine is largely dependent on the microbial 
population of the gut and the presence of dietary substances with ability 
to inhibit the TMA synthesis from carnitine, such as resveratrol or al-
licin (Chen et al., 2016; Wu et al., 2015). Other authors have found 
different TMAO blood levels in diabetic and non-diabetic cardiac pa-
tients, being strongly associated with different patterns of the intestinal 
microbiota (Sanchez-Alcoholado et al., 2017). Diabetic cardiac patients 
had higher TMAO levels, linked with less beneficial or commensal 
bacteria (such as Faecalibacterium prausnitzii and Bacteroides fragilis) and 
more opportunistic pathogens (such as Enterobacteriaceae, Streptococcus, 
and Desulfovibrio). The gut microbiota can, therefore, be proposed as a 
therapeutic target to reduce TMAO levels and thus the risk of CVD. Diet 
is considered to have the largest influence on gut microbial population 
makeup and function (Sheflin, Melby, Carbonero, & Weir, 2017). In 
fact, enterotypes have been clearly associated with long-term diets, 
particularly those rich in protein and animal fat in which Bacteroides 
was the prevalent genus, versus carbohydrate-rich diets in which Pre-
votella was mainly found (Wu et al., 2011). Changes in diet are able to 
modulate the microbiota depending on the amount, type and balance of 
the main dietary macronutrients (Scott, Gratz, Sheridan, Flint, & 
Duncan, 2013). For instance, urinary TMAO levels were lower when 
pigs consumed red meat in the context of a prudent vs. a western 
background diet (Thøgersen et al., 2020). However, healthy diets are 
not always followed by consumers in general, and by patients in par-
ticular. Therefore, the direct administration of pre- and/or probiotics 
might be a strategy to follow in order to modulate the gut microbiota in 
a beneficial way. 
Several substances have been described as microbial TMA in-
hibitors, thereupon reducing TMAO blood levels. For instance, a sig-
nificant reduction in TMAO level was achieved through antibiotic ad-
ministration, but TMAO blood levels were increased after antibiotics 
were discontinued (Tang et al., 2013). However, the chronic adminis-
tration of antibiotics is not recommended, thus, other alternatives have 
Fig. 3. Underlying mechanisms of the pathophysiological effects of carnitine on CVD.  
J. Delgado, et al.   Meat Science 171 (2021) 108278
8
been investigated. The ability of a choline analogue (3,3-dimethyl-1- 
butanol (DMB)) to inhibit TMA production and reduce TMAO levels in 
mice fed a high choline or carnitine diet, without microbial growth 
inhibition, has been demonstrated (Wang et al., 2015). A carnitine 
analogue, meldonium, also significantly reduced the production of 
TMA/TMAO from L-carnitine, but not from choline, and neither af-
fected bacterial growth (Kuka et al., 2014). Resveratrol, an antioxidant 
commonly found in red berries, has also been found to decrease plasma 
levels of TMA and TMAO (Annunziata et al., 2019). This antioxidant 
and antimicrobial substance achieved this reduction by modulating the 
microbiota, inhibiting commensal microbial TMA producers and in-
creasing levels of the genera Lactobacillus and Bifidobacterium (Chen 
et al., 2016). Similarly, allicin, a potent antimicrobial found in garlic, 
significantly reduced TMAO blood levels in mice fed with carnitine, 
through gut microbiota modulation (Wu et al., 2015). 
4. Concluding remarks 
Particular components of red and processed meat products dis-
cussed herewithin, namely, lipids and oxidized lipids, NaCl and carni-
tine, are associated to contribute to the occurrence of cardiovascular 
events by diverse means. Yet, the role of single components in chronic 
diseases cannot be easily extrapolated to the contribution of muscle 
foods containing such components. In fact, epidemiological studies re-
veal no authoritative connections between the intake of red and pro-
cessed meat and occurrence of CVD. Taking into consideration current 
scientific literature leads to inconsistencies and contradictory outcomes 
in relation to the influence of meat lipids and carnitine on CVD. The 
influence of dietary lipids on lipid metabolism and CVD is multifaceted 
and lipid oxidation may partly account for the negative impact of such 
relationship. Since dietary components such as fish, recurrently re-
cognized as cardioprotective, leads to considerably higher formation of 
n-3 PUFA oxidation products during digestion and higher plasma levels 
of TMAO than red meat, the intertwined role of lipid oxidation, car-
nitine and TMAO as promoters of increased blood pressure needs to be 
critically assessed. The contribution of processed meat to total NaCl 
intake, and the concomitant effect on CVD is likely the most established 
relationship discussed in this review. Hence, sodium reduction and/or 
replacement in meat processing is expected to have mitigating effects 
on CVD. Continued efforts should, therefore, be made by the meat in-
dustry to improve the formulation of processed meats so that they keep 
playing a relevant role in a healthy and nutritious diet. 
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